Datamatics Global Services Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 19, 2025, 2:30 am

Quick Insight

Datamatics Global Services Ltd, operating in the IT Consulting & Software industry, currently trades at a price of 926 with a market capitalization of 5,474 Cr. The company's financial metrics reveal a P/E ratio of 29.9, indicating investors' willingness to pay a premium for its earnings. With a ROE of 12.5% and ROCE of 15.0%, Datamatics shows efficient utilization of capital. A healthy OPM of 16% and a comfortable ICR of 146.73x suggest strong operational and financial health. Furthermore, the company's low debt level, with borrowings at 190Cr and a CCC of 64 days, indicates good liquidity and working capital management. Overall, Datamatics Global Services Ltd appears well-positioned for growth and profitability in the IT sector.

Competitors of Datamatics Global Services Ltd

All Competitor Stocks of Datamatics Global Services Ltd

Quarterly Result

Last Updated: August 20, 2025, 11:50 am

Below is a detailed analysis of the quarterly data for Datamatics Global Services Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 468.00 Cr.. The value appears to be declining and may need further review. It has decreased from 497.00 Cr. (Mar 2025) to 468.00 Cr., marking a decrease of 29.00 Cr..
• For Expenses, as of Jun 2025, the value is 392.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 423.00 Cr. (Mar 2025) to 392.00 Cr., marking a decrease of 31.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 75.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Mar 2025) to 16.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 20.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 64.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2025) to 64.00 Cr., marking an increase of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 21.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 21.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 50.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2025) to 50.00 Cr., marking an increase of 5.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 8.51. The value appears strong and on an upward trend. It has increased from 7.58 (Mar 2025) to 8.51, marking an increase of 0.93.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:44 pm

Balance Sheet

Last Updated: August 11, 2025, 1:52 pm

Below is a detailed analysis of the balance sheet data for Datamatics Global Services Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 30.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,335.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,200.00 Cr. (Mar 2024) to 1,335.00 Cr., marking an increase of 135.00 Cr..
• For Borrowings, as of Mar 2025, the value is 190.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 17.00 Cr. (Mar 2024) to 190.00 Cr., marking an increase of 173.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 502.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 217.00 Cr. (Mar 2024) to 502.00 Cr., marking an increase of 285.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,056.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,463.00 Cr. (Mar 2024) to 2,056.00 Cr., marking an increase of 593.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 839.00 Cr.. The value appears strong and on an upward trend. It has increased from 219.00 Cr. (Mar 2024) to 839.00 Cr., marking an increase of 620.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 355.00 Cr.. The value appears to be declining and may need further review. It has decreased from 546.00 Cr. (Mar 2024) to 355.00 Cr., marking a decrease of 191.00 Cr..
• For Other Assets, as of Mar 2025, the value is 862.00 Cr.. The value appears strong and on an upward trend. It has increased from 698.00 Cr. (Mar 2024) to 862.00 Cr., marking an increase of 164.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,056.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,463.00 Cr. (Mar 2024) to 2,056.00 Cr., marking an increase of 593.00 Cr..

Notably, the Reserves (1,335.00 Cr.) exceed the Borrowings (190.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Datamatics Global Services Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 33.60. This value is within the healthy range. It has increased from 32.05 (Mar 23) to 33.60, marking an increase of 1.55.
• For Diluted EPS (Rs.), as of Mar 24, the value is 33.60. This value is within the healthy range. It has increased from 32.05 (Mar 23) to 33.60, marking an increase of 1.55.
• For Cash EPS (Rs.), as of Mar 24, the value is 39.56. This value is within the healthy range. It has increased from 37.36 (Mar 23) to 39.56, marking an increase of 2.20.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 206.90. It has increased from 176.51 (Mar 23) to 206.90, marking an increase of 30.39.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 206.90. It has increased from 176.51 (Mar 23) to 206.90, marking an increase of 30.39.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 262.69. It has increased from 247.49 (Mar 23) to 262.69, marking an increase of 15.20.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 48.99. This value is within the healthy range. It has increased from 47.70 (Mar 23) to 48.99, marking an increase of 1.29.
• For PBIT / Share (Rs.), as of Mar 24, the value is 42.85. This value is within the healthy range. It has increased from 41.78 (Mar 23) to 42.85, marking an increase of 1.07.
• For PBT / Share (Rs.), as of Mar 24, the value is 42.51. This value is within the healthy range. It has increased from 41.28 (Mar 23) to 42.51, marking an increase of 1.23.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 33.41. This value is within the healthy range. It has increased from 31.43 (Mar 23) to 33.41, marking an increase of 1.98.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 33.59. This value is within the healthy range. It has increased from 32.05 (Mar 23) to 33.59, marking an increase of 1.54.
• For PBDIT Margin (%), as of Mar 24, the value is 18.64. This value is within the healthy range. It has decreased from 19.27 (Mar 23) to 18.64, marking a decrease of 0.63.
• For PBIT Margin (%), as of Mar 24, the value is 16.31. This value is within the healthy range. It has decreased from 16.88 (Mar 23) to 16.31, marking a decrease of 0.57.
• For PBT Margin (%), as of Mar 24, the value is 16.18. This value is within the healthy range. It has decreased from 16.68 (Mar 23) to 16.18, marking a decrease of 0.50.
• For Net Profit Margin (%), as of Mar 24, the value is 12.71. This value exceeds the healthy maximum of 10. It has increased from 12.70 (Mar 23) to 12.71, marking an increase of 0.01.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 12.78. This value is within the healthy range. It has decreased from 12.94 (Mar 23) to 12.78, marking a decrease of 0.16.
• For Return on Networth / Equity (%), as of Mar 24, the value is 16.12. This value is within the healthy range. It has decreased from 18.03 (Mar 23) to 16.12, marking a decrease of 1.91.
• For Return on Capital Employeed (%), as of Mar 24, the value is 19.89. This value is within the healthy range. It has decreased from 22.48 (Mar 23) to 19.89, marking a decrease of 2.59.
• For Return On Assets (%), as of Mar 24, the value is 13.54. This value is within the healthy range. It has decreased from 14.74 (Mar 23) to 13.54, marking a decrease of 1.20.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.13. It has decreased from 1.22 (Mar 23) to 1.13, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 24, the value is 4.90. This value exceeds the healthy maximum of 3. It has decreased from 4.93 (Mar 23) to 4.90, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 24, the value is 4.90. This value exceeds the healthy maximum of 2. It has decreased from 4.93 (Mar 23) to 4.90, marking a decrease of 0.03.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 15.03. This value is below the healthy minimum of 20. It has increased from 3.90 (Mar 23) to 15.03, marking an increase of 11.13.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 12.71. This value is below the healthy minimum of 20. It has increased from 3.29 (Mar 23) to 12.71, marking an increase of 9.42.
• For Earning Retention Ratio (%), as of Mar 24, the value is 84.97. This value exceeds the healthy maximum of 70. It has decreased from 96.10 (Mar 23) to 84.97, marking a decrease of 11.13.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 87.29. This value exceeds the healthy maximum of 70. It has decreased from 96.71 (Mar 23) to 87.29, marking a decrease of 9.42.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 146.73. This value is within the healthy range. It has increased from 96.66 (Mar 23) to 146.73, marking an increase of 50.07.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 101.07. This value is within the healthy range. It has increased from 64.69 (Mar 23) to 101.07, marking an increase of 36.38.
• For Enterprise Value (Cr.), as of Mar 24, the value is 3,008.13. It has increased from 1,513.96 (Mar 23) to 3,008.13, marking an increase of 1,494.17.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.94. This value is within the healthy range. It has increased from 1.04 (Mar 23) to 1.94, marking an increase of 0.90.
• For EV / EBITDA (X), as of Mar 24, the value is 10.41. This value is within the healthy range. It has increased from 5.38 (Mar 23) to 10.41, marking an increase of 5.03.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.03. This value is within the healthy range. It has increased from 1.15 (Mar 23) to 2.03, marking an increase of 0.88.
• For Retention Ratios (%), as of Mar 24, the value is 84.96. This value exceeds the healthy maximum of 70. It has decreased from 96.09 (Mar 23) to 84.96, marking a decrease of 11.13.
• For Price / BV (X), as of Mar 24, the value is 2.56. This value is within the healthy range. It has increased from 1.60 (Mar 23) to 2.56, marking an increase of 0.96.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.03. This value is within the healthy range. It has increased from 1.15 (Mar 23) to 2.03, marking an increase of 0.88.
• For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 23) to 0.06, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness